These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20350654)

  • 21. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
    Abaterusso C; Pertica N; Lupo A; Ortalda V; Gambaro G
    Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
    Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
    Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and management of chronic kidney disease in children: Guidelines of the French Society of Pediatric Nephrology].
    Pietrement C; Allain-Launay E; Bacchetta J; Bertholet-Thomas A; Dubourg L; Harambat J; Vieux R; Deschênes G;
    Arch Pediatr; 2016 Nov; 23(11):1191-1200. PubMed ID: 27743765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of chronic kidney disease in a general medicine outpatient clinic.
    MacDougall-Rivers M; Phillips L
    Ren Fail; 2011; 33(9):853-8. PubMed ID: 21859402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyslipidemia in chronic kidney disease: managing a high-risk combination.
    Chauhan V; Vaid M
    Postgrad Med; 2009 Nov; 121(6):54-61. PubMed ID: 19940417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism.
    Alfieri C; Regalia A; Zanoni F; Vettoretti S; Cozzolino M; Messa P
    Blood Purif; 2019; 47(1-3):37-44. PubMed ID: 30223271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CE: Continuing Education article. Patient management in chronic kidney disease stages 4 to 5.
    Murphy F; Jenkins K; McCann M; Sedgewick J
    J Ren Care; 2008 Dec; 34(4):191-8. PubMed ID: 19090897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing advanced chronic kidney disease: a primary care guide.
    Sakhuja A; Hyland J; Simon JF
    Cleve Clin J Med; 2014 May; 81(5):289-99. PubMed ID: 24789588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
    Singh AK; Hertello P
    Nephrol Nurs J; 2005; 32(2):199-206; quiz 207-8. PubMed ID: 15889804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anemia in children with chronic kidney disease.
    Greenbaum LA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):385-96. PubMed ID: 16198278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does correction of anemia slow the progression of chronic kidney disease?
    Singh AK
    Nat Clin Pract Nephrol; 2007 Dec; 3(12):638-9. PubMed ID: 17940523
    [No Abstract]   [Full Text] [Related]  

  • 33. Anemia and bone disease of chronic kidney disease: pathogenesis, diagnosis, and management.
    Shemin D
    R I Med J (2013); 2014 Dec; 97(12):24-7. PubMed ID: 25463623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron therapy in chronic kidney disease: current controversies.
    Kovesdy CP; Kalantar-Zadeh K
    J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acupuncture Application in Chronic Kidney Disease and its Potential Mechanisms.
    Xiong W; He FF; You RY; Xiong J; Wang YM; Zhang C; Meng XF; Su H
    Am J Chin Med; 2018; 46(6):1169-1185. PubMed ID: 30286626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic guidelines fulfillment in clinical practice in patients with chronic kidney disease (CKD)].
    Verdalles U; García de Vinuesa S; Goicoechea M; Gómez Campderá F; Luño J
    Nefrologia; 2007; 27(3):320-8. PubMed ID: 17725451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical practice guideline for anemia management in chronic kidney disease].
    Croatian Society of Nephrology, Dialysis and Transplantation, Croatian Medical Association
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():78-88. PubMed ID: 20232557
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme.
    Soares CM; Diniz JS; Lima EM; Oliveira GR; Canhestro MR; Colosimo EA; Simoes e Silva AC; Oliveira EA
    Nephrol Dial Transplant; 2009 Mar; 24(3):848-55. PubMed ID: 18840891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic kidney disease--management update.
    Johnson DW; Usherwood T
    Aust Fam Physician; 2005 Nov; 34(11):915-23. PubMed ID: 16299624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.